About Shanghai B&C Pharmaceutical
Shanghai B&C Pharmaceutical is a company based in Xuzhou (China) founded in 2010 by Zhiwei Fu and Fu Zhiwei.. Shanghai B&C Pharmaceutical has raised $130.52 million across 5 funding rounds from investors including CGP Investment, Zhongping Capital and Guokai Technology Venture Investment. Shanghai B&C Pharmaceutical operates in a competitive market with competitors including Inpria and Jiangsu Boyan Electronic Technology, among others.
- Headquarter Xuzhou, China
- Founders Zhiwei Fu, Fu Zhiwei
- Stage Unicorn
-
Sectors
Chemicals & Materials
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130.52 M (USD)
in 5 rounds
-
Latest Funding Round
$87.02 M (USD), Series C
Apr 24, 2023
-
Investors
CGP Investment
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai B&C Pharmaceutical
Shanghai B&C Pharmaceutical has successfully raised a total of $130.52M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $87.02 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $87.0M
-
First Round
First Round
(01 Aug 2021)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series C - Shanghai B&C Pharmaceutical | Valuation | Zhongping Capital , Guokai Technology Venture Investment | |
| Jun, 2022 | Amount | Series C - Shanghai B&C Pharmaceutical | Valuation |
investors |
|
| Jun, 2022 | Amount | Series C - Shanghai B&C Pharmaceutical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai B&C Pharmaceutical
Shanghai B&C Pharmaceutical has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include CGP Investment, Zhongping Capital and Guokai Technology Venture Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai B&C Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai BC Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai B&C Pharmaceutical Comparisons
Competitors of Shanghai B&C Pharmaceutical
Shanghai B&C Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inpria and Jiangsu Boyan Electronic Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Inorganic photoresists and thin films for semiconductor lithography are supplied.
|
|
| domain | founded_year | HQ Location |
Photoresist products are manufactured in Wuxi, China, since 2014.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Shanghai B&C Pharmaceutical
When was Shanghai B&C Pharmaceutical founded?
Shanghai B&C Pharmaceutical was founded in 2010 and raised its 1st funding round 11 years after it was founded.
Where is Shanghai B&C Pharmaceutical located?
Shanghai B&C Pharmaceutical is headquartered in Xuzhou, China. It is registered at Xuzhou, Jiangsu, China.
Is Shanghai B&C Pharmaceutical a funded company?
Shanghai B&C Pharmaceutical is a funded company, having raised a total of $130.52M across 5 funding rounds to date.
What does Shanghai B&C Pharmaceutical do?
Shanghai BC Pharmaceutical was established in 2010 in Xuzhou, China, focusing on the semiconductor sector. Photoresists, monomers, resins, and associated chemicals are produced for industrial use. A platform is offered to support photoresist manufacturing processes. Operations center on supplying raw materials to clients in the electronics and chemical industries, with distribution primarily in Asia.
Who are the top competitors of Shanghai B&C Pharmaceutical?
Shanghai B&C Pharmaceutical's top competitors include Inpria and Jiangsu Boyan Electronic Technology.
Who are Shanghai B&C Pharmaceutical's investors?
Shanghai B&C Pharmaceutical has 11 investors. Key investors include CGP Investment, Zhongping Capital, Guokai Technology Venture Investment, NEW HOPE CAPITAL, and V Fund.
What is Shanghai B&C Pharmaceutical's valuation?
The valuation of Shanghai B&C Pharmaceutical is $1B as of Apr 2023.